Chapter1: Making Economics Decisions
Section: Chapter Questions
Problem 1QTC
Related questions
Question
![The Core Principles of Economics
End of Chapter Problem
In 2016, the top-selling pharmaceutical drug in the world was AbbVie's Humira, which is used for the treatment of several
common, chronic conditions. The majority of its profits are derived from treatment of the most common diseases, but AbbVie
also develops drugs for rare conditions.
Why might AbbVie develop drugs for rare diseases instead of investing all of its resources toward drugs for common diseases?
It is possible that
the interdependence principle may be guiding AbbVie to develop and produce drugs for rare conditions. Common
chronic and rare conditions are often experienced by the same people, so AbbVie can easily produce drugs for both.
the opportunity-cost principle may encourage AbbVie to produce drugs for rare conditions, because the full benefits
outweigh the costs. The company must be maximizing its total economic surplus.
O framing effects may be enticing AbbVie to develop and produce drugs for rare conditions. Since these drugs are more
expensive, AbbVie will make a large profit.
the marginal principle may be guiding AbbVie in determining if it is worth producing drugs for rare diseases. Since it
is developing and producing treatments for rare diseases, the marginal benefits must exceed the costs.](/v2/_next/image?url=https%3A%2F%2Fcontent.bartleby.com%2Fqna-images%2Fquestion%2F8aa0e649-7d9d-4eef-b9bf-7f22732d0bcd%2F396daac0-3c71-444c-984a-581f3ee33fd6%2Fnb9wv69_processed.jpeg&w=3840&q=75)
Transcribed Image Text:The Core Principles of Economics
End of Chapter Problem
In 2016, the top-selling pharmaceutical drug in the world was AbbVie's Humira, which is used for the treatment of several
common, chronic conditions. The majority of its profits are derived from treatment of the most common diseases, but AbbVie
also develops drugs for rare conditions.
Why might AbbVie develop drugs for rare diseases instead of investing all of its resources toward drugs for common diseases?
It is possible that
the interdependence principle may be guiding AbbVie to develop and produce drugs for rare conditions. Common
chronic and rare conditions are often experienced by the same people, so AbbVie can easily produce drugs for both.
the opportunity-cost principle may encourage AbbVie to produce drugs for rare conditions, because the full benefits
outweigh the costs. The company must be maximizing its total economic surplus.
O framing effects may be enticing AbbVie to develop and produce drugs for rare conditions. Since these drugs are more
expensive, AbbVie will make a large profit.
the marginal principle may be guiding AbbVie in determining if it is worth producing drugs for rare diseases. Since it
is developing and producing treatments for rare diseases, the marginal benefits must exceed the costs.
Expert Solution
![](/static/compass_v2/shared-icons/check-mark.png)
This question has been solved!
Explore an expertly crafted, step-by-step solution for a thorough understanding of key concepts.
This is a popular solution!
Trending now
This is a popular solution!
Step by step
Solved in 3 steps
![Blurred answer](/static/compass_v2/solution-images/blurred-answer.jpg)
Knowledge Booster
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, economics and related others by exploring similar questions and additional content below.Recommended textbooks for you
![ENGR.ECONOMIC ANALYSIS](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9780190931919/9780190931919_smallCoverImage.gif)
![Principles of Economics (12th Edition)](https://www.bartleby.com/isbn_cover_images/9780134078779/9780134078779_smallCoverImage.gif)
Principles of Economics (12th Edition)
Economics
ISBN:
9780134078779
Author:
Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher:
PEARSON
![Engineering Economy (17th Edition)](https://www.bartleby.com/isbn_cover_images/9780134870069/9780134870069_smallCoverImage.gif)
Engineering Economy (17th Edition)
Economics
ISBN:
9780134870069
Author:
William G. Sullivan, Elin M. Wicks, C. Patrick Koelling
Publisher:
PEARSON
![ENGR.ECONOMIC ANALYSIS](https://compass-isbn-assets.s3.amazonaws.com/isbn_cover_images/9780190931919/9780190931919_smallCoverImage.gif)
![Principles of Economics (12th Edition)](https://www.bartleby.com/isbn_cover_images/9780134078779/9780134078779_smallCoverImage.gif)
Principles of Economics (12th Edition)
Economics
ISBN:
9780134078779
Author:
Karl E. Case, Ray C. Fair, Sharon E. Oster
Publisher:
PEARSON
![Engineering Economy (17th Edition)](https://www.bartleby.com/isbn_cover_images/9780134870069/9780134870069_smallCoverImage.gif)
Engineering Economy (17th Edition)
Economics
ISBN:
9780134870069
Author:
William G. Sullivan, Elin M. Wicks, C. Patrick Koelling
Publisher:
PEARSON
![Principles of Economics (MindTap Course List)](https://www.bartleby.com/isbn_cover_images/9781305585126/9781305585126_smallCoverImage.gif)
Principles of Economics (MindTap Course List)
Economics
ISBN:
9781305585126
Author:
N. Gregory Mankiw
Publisher:
Cengage Learning
![Managerial Economics: A Problem Solving Approach](https://www.bartleby.com/isbn_cover_images/9781337106665/9781337106665_smallCoverImage.gif)
Managerial Economics: A Problem Solving Approach
Economics
ISBN:
9781337106665
Author:
Luke M. Froeb, Brian T. McCann, Michael R. Ward, Mike Shor
Publisher:
Cengage Learning
![Managerial Economics & Business Strategy (Mcgraw-…](https://www.bartleby.com/isbn_cover_images/9781259290619/9781259290619_smallCoverImage.gif)
Managerial Economics & Business Strategy (Mcgraw-…
Economics
ISBN:
9781259290619
Author:
Michael Baye, Jeff Prince
Publisher:
McGraw-Hill Education